Scientific articles 27 Mar 2026 Prognostic models predicting clinical outcomes in patients diagnosed with visceral leishmaniasis: a systematic review BMJ Public Health
Scientific articles 14 Jan 2026 (Un)intended consequences: a social sciences stocktake of a decade of Global Action Plan-inspired antimicrobial governance The Lancet Microbe
Scientific articles 24 Mar 2026 The burden of eumycetoma in Africa: a neglected fungal disease The Lancet Regional Health – Africa
Statements 23 Mar 2026 DNDi statement at the sixth meeting of the Intergovernmental Working Group (IGWG) on the WHO Pandemic Agreement
In the media 15 Mar 2026 Tres pastillas en una dosis única, la bala de plata contra la enfermedad del sueño El Periódico
In the media 14 Mar 2026 Africa’s one-dose cure brings sleeping sickness elimination within reach The Independent
Scientific articles 9 Jan 2026 Skin pharmacokinetics and pharmacodynamics in patients with post-kala-azar dermal leishmaniasis International Journal of Antimicrobial Agents
Scientific articles 9 Jan 2026 Target product profile for the development of pediatric formulations of new drugs for the treatment of children with T. cruzi infection PLOS Neglected Tropical Diseases
Scientific articles 9 Jan 2026 Global health is in crisis: to reach neglected patients, we need to reimagine medical research BMJ Global Health
Scientific articles 17 Dec 2025 Kronopolitides A–F, a family of 36-membered polyol macrolides with antiparasitic activity against Chagas disease Journal of Natural Products
Scientific articles 2 Dec 2025 The development of a global research agenda and individual participant data platform for visceral leishmaniasis: challenges and future opportunities Parasites & Vectors
Scientific articles 25 Nov 2025 Bidirectional interaction between liposomal amphotericin B pharmacokinetics and parasite dynamics in patients with post-kala-azar dermal leishmaniasis: Potential implications for optimal dosing Clinical Pharmacology & Therapeutics
Scientific articles 20 Nov 2025 Safety, tolerability and pharmacokinetics of DNDI-6148, a novel agent for leishmaniasis: A randomized, controlled, single ascending dose study in healthy participants British Journal of Clinical Pharmacology
Scientific articles 4 Nov 2025 Host-derived molecules as novel chagas disease biomarkers: hypercoagulability markers and extracellular vesicles Methods in Molecular Biology
Scientific articles 30 Oct 2025 Target product profile and discovery and development path for novel cryptococcal disease treatments Journal of Infection
Scientific articles 7 Oct 2025 Core outcome measurement set for clinical trials in dengue: an international Delphi consensus study (DEN-CORE) The Lancet Infectious Diseases
Scientific articles 30 Sep 2025 New regimens of benznidazole for the treatment of chronic Chagas disease in adult participants in indeterminate form or with mild cardiac progression (NuestroBen study): protocol for a phase III randomised, multicentre non-inferiority clinical trial BMJ Open
Scientific articles 29 Sep 2025 Performance evaluation of rapid diagnostic tests for Chagas disease in Jutiapa, Guatemala Journal of the Brazilian Society of Tropical Medicine
Scientific articles 22 Sep 2025 Mass balance, pharmacokinetics, metabolism, and excretion of radiolabeled acoziborole, a potential novel treatment for human African trypanosomiasis, following single microtracer oral dose to humans Antimicrobial Agents and Chemotherapy
Scientific articles 18 Sep 2025 Structure–activity relationships of fenarimol analogues with potent in vitro and in vivo activity against Madurella mycetomatis, the main causative agent of eumycetoma RSC Medicinal Chemistry
Scientific articles 8 Sep 2025 Quantifying anti-trypanosomal treatment effects in chronic indeterminate Chagas disease: a secondary analysis of individual patient data from two proof-of-concept trials The Lancet Microbe
